144 related articles for article (PubMed ID: 30809471)
1. Effect of topical 0.05% cyclosporine A on the tear protein lacritin in a rat model of dry eye.
Zhang FD; Hao ZQ; Gao W; Xing YQ
Int J Ophthalmol; 2019; 12(2):189-193. PubMed ID: 30809471
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 0.025% FK-506, 0.05% Cyclosporin A, and 0.3% Sodium Hyaluronate Eye Drops for the Treatment of Botulinum Toxin B-Induced Mouse Dry Eye.
Lin BW; Huang WL; Wang L; Chen ZM
J Ocul Pharmacol Ther; 2018 Nov; 34(9):633-641. PubMed ID: 30227093
[TBL] [Abstract][Full Text] [Related]
3. Lacritin, a novel human tear glycoprotein, promotes sustained basal tearing and is well tolerated.
Samudre S; Lattanzio FA; Lossen V; Hosseini A; Sheppard JD; McKown RL; Laurie GW; Williams PB
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6265-70. PubMed ID: 21087963
[TBL] [Abstract][Full Text] [Related]
4. Topical administration of lacritin is a novel therapy for aqueous-deficient dry eye disease.
Vijmasi T; Chen FY; Balasubbu S; Gallup M; McKown RL; Laurie GW; McNamara NA
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5401-9. PubMed ID: 25034600
[TBL] [Abstract][Full Text] [Related]
5. Lacritin-induced secretion of tear proteins from cultured monkey lacrimal acinar cells.
Fujii A; Morimoto-Tochigi A; Walkup RD; Shearer TR; Azuma M
Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2533-40. PubMed ID: 23482462
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic effects of Pyranoprofen on the mouse dry eye induced by topical medication of Benzalkonium Chloride].
He H; Liu ZG; Lin ZR; Liu XC; He H; Xiao QG
Zhonghua Yan Ke Za Zhi; 2012 Jan; 48(1):33-40. PubMed ID: 22490914
[TBL] [Abstract][Full Text] [Related]
7. Lacritin and the tear proteome as natural replacement therapy for dry eye.
Karnati R; Laurie DE; Laurie GW
Exp Eye Res; 2013 Dec; 117():39-52. PubMed ID: 23769845
[TBL] [Abstract][Full Text] [Related]
8. A mouse dry eye model induced by topical administration of the air pollutant particulate matter 10.
Li J; Tan G; Ding X; Wang Y; Wu A; Yang Q; Ye L; Shao Y
Biomed Pharmacother; 2017 Dec; 96():524-534. PubMed ID: 29032336
[TBL] [Abstract][Full Text] [Related]
9. Effect of topical olopatadine and epinastine in the botulinum toxin B-induced mouse model of dry eye.
Lekhanont K; Park CY; Combs JC; Suwan-Apichon O; Rangsin R; Chuck RS
J Ocul Pharmacol Ther; 2007 Feb; 23(1):83-8. PubMed ID: 17341156
[TBL] [Abstract][Full Text] [Related]
10. The effects of estrogen and androgen on tear secretion and matrix metalloproteinase-2 expression in lacrimal glands of ovariectomized rats.
Song X; Zhao P; Wang G; Zhao X
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):745-51. PubMed ID: 24334444
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin B-induced mouse model of keratoconjunctivitis sicca.
Suwan-apichon O; Rizen M; Rangsin R; Herretes S; Reyes JM; Lekhanont K; Chuck RS
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):133-9. PubMed ID: 16384954
[TBL] [Abstract][Full Text] [Related]
12. Lacritin proteoforms prevent tear film collapse and maintain epithelial homeostasis.
Georgiev GA; Gh MS; Romano J; Dias Teixeira KL; Struble C; Ryan DS; Sia RK; Kitt JP; Harris JM; Hsu KL; Libby A; Odrich MG; Suárez T; McKown RL; Laurie GW
J Biol Chem; 2021; 296():100070. PubMed ID: 33187980
[TBL] [Abstract][Full Text] [Related]
13. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
Toker E; Asfuroğlu E
Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
[TBL] [Abstract][Full Text] [Related]
14. Lacritin and other new proteins of the lacrimal functional unit.
McKown RL; Wang N; Raab RW; Karnati R; Zhang Y; Williams PB; Laurie GW
Exp Eye Res; 2009 May; 88(5):848-58. PubMed ID: 18840430
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a new topical cationic emulsion of cyclosporine A on dry eye clinical signs in an experimental mouse model of dry eye.
Daull P; Feraille L; Barabino S; Cimbolini N; Antonelli S; Mauro V; Garrigue JS
Exp Eye Res; 2016 Dec; 153():159-164. PubMed ID: 27777121
[TBL] [Abstract][Full Text] [Related]
16. Tear lacritin levels by age, sex, and time of day in healthy adults.
Seifert K; Gandia NC; Wilburn JK; Bower KS; Sia RK; Ryan DS; Deaton ML; Still KM; Vassilev VC; Laurie GW; McKown RL
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6610-6. PubMed ID: 22918641
[TBL] [Abstract][Full Text] [Related]
17. Comparison of topical dry eye medications for the treatment of keratoconjunctivitis sicca in a botulinum toxin B-induced mouse model.
Lekhanont K; Leyngold IM; Suwan-Apichon O; Rangsin R; Chuck RS
Cornea; 2007 Jan; 26(1):84-9. PubMed ID: 17198019
[TBL] [Abstract][Full Text] [Related]
18. Effect of natural extract eye drops in dry eye disease rats.
Choi SY; Eom Y; Kim JY; Jang DH; Song JS; Kim HM
Int J Ophthalmol; 2020; 13(7):1023-1030. PubMed ID: 32685387
[TBL] [Abstract][Full Text] [Related]
19. Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye.
Nagelhout TJ; Gamache DA; Roberts L; Brady MT; Yanni JM
J Ocul Pharmacol Ther; 2005 Apr; 21(2):139-48. PubMed ID: 15857280
[TBL] [Abstract][Full Text] [Related]
20. [The protection of hydrogen-rich saline on a rat dry eye model induced by scopolamine hydrobromide].
Chu YY; Hua N; Ru YS; Zhao SZ
Zhonghua Yan Ke Za Zhi; 2017 May; 53(5):363-372. PubMed ID: 28494565
[No Abstract] [Full Text] [Related]
[Next] [New Search]
